comparemela.com


Editorial Article: Accelerated production of novel immunotherapies with high-throughput screening
Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc. discusses the cutting-edge technology transforming the identification of new targets for the development of effective immunotherapeutics
29 Jul 2021
Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc.
A major challenge in the development and production of immunotherapeutics is the shortage of novel targets that can be exploited. To tackle this, NextCure, a fully integrated clinical-stage biopharmaceutical company, is working hard to accelerate the development of cancer therapeutics and improve patient care, by identifying potential targets through advanced high-throughput screening techniques such as flow cytometry and cell sorting.

Related Keywords

Dallas ,Texas ,United States , ,Discovery Research ,Discovery Research At Nextcure ,Discovery Research Department ,Nextcure Inc ,Editorial Article ,Dallas Flies ,Vice President ,Cell Sorter ,Integrated Nextcure Discovery ,Immune Oncology ,Cell Sorters ,டல்லாஸ் ,டெக்சாஸ் ,ஒன்றுபட்டது மாநிலங்களில் ,கண்டுபிடிப்பு ஆராய்ச்சி ,கண்டுபிடிப்பு ஆராய்ச்சி துறை ,தலையங்கம் கட்டுரை ,துணை ப்ரெஸிடெஂட் ,செல் ஸார்‌டர் ,நோய் எதிர்ப்பு சக்தி புற்றுநோயியல் ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.